Clinical Trials Directory

Trials / Completed

CompletedNCT03761979

Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
BioLink Life Sciences, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

No clinical trials have evaluated strontium L-lactate (SrLac), the strontium salt of the L-enantiomer of lactic acid. Therefore, this clinical study was conducted to obtain general safety and pharmacokinetic (PK) information following acute oral intakes of three doses of SrLac by healthy adults. The data provided valuable comparisons with the pharmacokinetics of other strontium salts that are in clinical use and allowed determination of the dose of SrLac that will be useful for the management of bone health.neficial for the treatment of low bone density of osteoporosis and osteopenia.

Detailed description

Purpose: The aim of this clinical study was to obtain safety and pharmacokinetic information following acute oral intakes of three ascending doses of strontium L-lactate by healthy adults. Subjects and methods: Ten healthy men and women, mean age 43 ± 2 years, ingested one of three ascending doses of strontium L-lactate (SrLac) once per week for three weeks in succession. Fasting blood collections were performed pre-dose and 1, 2, 3, 4, 5, 6, 8 and 12 hours post-dose for determination of serum strontium at each interval.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStrontium L-lactateThe Study Product was a highly pure form of SrLac, the strontium salt of L-lactic acid. SrLac was manufactured in compliance with current Good Manufacturing Practices. SrLac was thoroughly tested and met rigorous purity specifications. It was free from contamination by D-lactic acid and trace metals known to harm human health.

Timeline

Start date
2017-03-09
Primary completion
2017-06-01
Completion
2017-07-17
First posted
2018-12-03
Last updated
2018-12-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03761979. Inclusion in this directory is not an endorsement.